ABCC1 and breast carcinoma: As reported, multidrug resistance-associated protein 1 (MRP1, also known as ABCC1) expression level was closely correlated with adverse chemotherapy outcomes in various cancers, including breast cancer, acute myeloid leukemia and non-small cell lung cancer [6, 7].